Accredited Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$917K Sell
200
-3,050
-94% -$885K 0.68% 31
2025
Q2
$907K Buy
+3,250
New +$921K 0.74% 32
2025
Q1
Sell
-3,250
Closed -$847K 369
2024
Q4
$847K Buy
+3,250
New +$964K 0.74% 29

Other funds holding AMGN

Accredited Wealth Management's AMGN Position: Q3 2025 in Review

Accredited Wealth Management reduced its Amgen (AMGN) stake by 94% in Q3 2025, selling an estimated $885K and leaving 200 shares worth $917K. The position accounts for 0.68% of the portfolio, ranked #31.

Accredited Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 3 quarters since. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Accredited Wealth Management held 200 shares of Amgen worth $917K as of Q3 2025.
  • Accredited Wealth Management sold 3,050 Amgen shares in Q3 2025, an estimated $885K.
  • Amgen made up 0.68% of Accredited Wealth Management's portfolio in Q3 2025, its #31 holding.
  • Accredited Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 3 quarters since.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.